Angiotensin II type 1 receptor mRNA and its protein expression in human pancreatic cancer cell lines

Chinese Journal of Digestive Diseases

Volumn 5, Issue 2, 2004, Pages 68-71

  Jiang, Hua ^a,b   Li, Zhao Shen ^a   Xu, Guo Ming ^a   Tu, Zhen Xing ^a   Gong, Yan Fang ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b Nanjing 81 Hospital   (China)

Author keywords

Angiotensin II; Angiotensin II type 1 receptor; Pancreatic cancer

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; MESSENGER RNA;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CELL MEMBRANE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; GENE EXPRESSION; HORMONE INHIBITION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; PANCREAS CANCER; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CELL LINE, TUMOR; HUMANS; PANCREATIC NEOPLASMS; RECEPTOR, ANGIOTENSIN, TYPE 1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 2342570909     PISSN: 14439611     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1443-9573.2004.00158.x     Document Type: Article

References (14)

1. Rosenberg L. Pancreatic cancer: a review of emerging therapies. Drugs 2000; 59: 1071-89.
2. Evans DB, Abbruzzese JL, Rich TR. Cancer of the pancreas. In: De Vita VT, Hellman S, Rosenberg SA, eds. Cancer Principles and Practice of Oncology, 5th edn. New York: Lippincott-Raven, 1997; 1054-87.
3. Regine WF, John WJ, Mohiuddin M. Current and emerging treatments for pancreatic cancer. Drugs Aging 1997; 11: 285-95.
4. Johnson LR. Effect of gastrointestinal hormones on pancreatic growth. Cancer 1981; 47(Suppl 6): 1640-5.
5. Edwards BF, Redding TW, Schally AV. The effect of gastrointestinal hormones on the incorporation of tritiated thymidine in the pancreatic adenocarcinoma cell line (WD PaCa). Int J Pancreatol 1989; 5: 191-201.
6. Chiu AT, Herblin WF, McCall DE et al. Identification of angiotensin II receptor subtypes. Biochem Biophys Res Commun 1989; 165: 196-203.
7. Nishizuka Y. The molecular heterogeneity of protein kinase C and its implications for cellular regulation. Nature 1988; 334: 661-5.
8. Lam KY, Leung PS. Regulation and expression of a renin-angiotensin system in human pancreas and pancreatic endocrine tumors. Eur J Endocrinol 2002; 146: 567-72.
9. De Paepe B, Verstraeten VL, De Potter CR et al. Growth stimulatory angiotensin II type 1 receptor is upregulated, in breast hyperplasia and in situ carcinoma but not in invasive carcinoma. Histochem Cell Biol 2001; 116: 247-54.
10. Takeda H, Kondo S. Differences between squamous cell carcinoma and keratoacanthoma in angiotensin type-1 receptor expression. Am J Pathol 2001; 158: 1633-7.
11. Rivera E, Arrieta O, Guevara P et al. AT1 receptor is present in glioma cells; its blockage reduces the growth of rat glioma. Br J Cancer 2001; 85: 1396-9.
12. Tanabe A, Naruse M, Naruse K et al. Angiotensin II type 1 receptor expression in two cases of juxtaglomerular cell tumor: correlation to negative feedback of renin secretion by angiotensin II. Horm Metab Res 1999; 31: 429-34.
13. Chen YM, Wu KD, Hu Tsai MI et al. Differential expression of type 1 angiotensin II receptor mRNA and aldosterone responsiveness to angiotensin in aldosterone-producing adenoma. Mol Cell Endocrinol 1999; 152: 47-55.
14. Fujimoto Y, Sasaki T, Tsuchida A et al. Angiotensin II type 1 receptor expression in human pancreatic cancer and growth inhibition by angiotensin II type 1 receptor antagonist. FEBS Lett 2001; 495: 197-200.